Navigation Links
Genzyme Corporation Selects Diplomat Specialty Pharmacy for 2008 Renagel Medicare Part D Assistance Program
Date:1/17/2008

FLINT, Mich., Jan. 17 /PRNewswire/ -- Diplomat Specialty Pharmacy, one of the largest privately owned national specialty pharmacies, announced today that it has entered into an agreement with Genzyme Corporation to administer their 2008 Renagel Medicare Part D Assistance Program. Genzyme is one the world's largest biotechnology companies dedicated to products and services focused in kidney disease, rare inherited disorders, orthopedics, transplant, and oncology.

Diplomat will be the 2008 national Part D Assistance provider for Renagel(R) (sevelamer hydrochloride). Renagel is a non-calcium/non-metal based phosphorus binder indicated for the control of serum phosphorus in patients with Chronic Kidney Disease (CKD) on dialysis. The Renagel Part D Assistance Program provides Renagel free of charge to patients who are enrolled in a Medicare Prescription Drug Plan but cannot afford their copayments or co-insurance payments for Renagel. The Renagel Part D Assistance program complements Diplomat's existing renal program which includes pharmacy delivery of required medications to dialysis patients and CKD disease management.

"Genzyme Corporation selected Diplomat Specialty Pharmacy to administer our 2008 Renagel Medicare Part D Assistance Program because of their understanding of the renal sector and reputation for providing a high level of customer service for over 30 years," stated Robin Goldwater, Director of Reimbursement & Specialty Services of Genzyme Corporation. "Our group will work closely with the Diplomat team to help qualified patients receive free Renagel.

"Diplomat is honored to be chosen as Genzyme's pharmacy partner for the 2008 Renagel Medicare Part D Assistance program," stated Phil Hagerman RPh, President/CEO of Diplomat Specialty Pharmacy. "Diplomat's experience and commitment to patients with Chronic Kidney Disease will help support Genzyme's premier national renal program that will assist dialysis patients to gain access to r
'/>"/>

SOURCE Diplomat Specialty Pharmacy
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Genzyme Completes Enrollment in Pivotal, Phase 2 Clinical Trial of Clofarabine in Adult AML
2. Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis
3. Genzyme Announces Second Pivotal Mozobil Trial Meets Primary Endpoint
4. CEL-SCI Corporation Announces 2007 Financial Results
5. Berkery Noyes Represented The Thomson Corporation in the Sale of CenterWatch and New England Institutional Review Board to Jobson Medical Information
6. AmpliMed Corporation Announces Promising 1-year Survival Data from Phase I/II Study of Amplimexon(R) in Metastatic Malignant Melanoma
7. Immunosyn Corporation Releases SF-1019 Study Results
8. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation
9. Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting
10. The Quigley Corporation Reports Third Quarter Results, Increases Investment in Pharmaceutical R&D for Diabetic Neuropathy
11. Genaera Corporation Presents Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... HILL, N.C. , May 22, 2015 /PRNewswire/ ... critical to pharmaceutical brand recognition and success. ... LLC conducted a study to provide pharmaceutical and ... of investment (FTEs and budget) that are being ... Pharmaceutical and biotech marketing managers can utilize this ...
(Date:5/22/2015)... , May 22, 2015 Electrophysiologist Kevin ... recently traveled to Boston, MA ... the 2015 Heart Rhythm Society conference. These scientific ... focus on the ideas, people and technology that ... is a hybrid, minimally invasive cardiac operation that ...
(Date:5/22/2015)... 22, 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX), a ... and regeneration, today announced that J.J. Finkelstein , ... a corporate overview at two upcoming investor conferences. ... 4 th Annual Microcap Conference on Thursday May ... at 11:00 am EDT.  A webcast will be ...
Breaking Medicine Technology:Effective Marketing Services Group Critical for Pharmaceutical Brand Recognition 2St. Joseph's Hospital Heart Institute Physician Presents at Heart Rhythm Society 2St. Joseph's Hospital Heart Institute Physician Presents at Heart Rhythm Society 3RegeneRx to Present at 2 Investor Conferences 2RegeneRx to Present at 2 Investor Conferences 3
... Feb. 1, 2011 Reportlinker.com announces that a new ... Personalized Medicine - scientific & commercial ... Summary The aim of ... right drug to the right patient and, in some ...
... of Dermatology, Laser and Cosmetics is now offering Alma Lasers ... Boerne area to treat superficial vascular and pigmented irregularities and ... add this new service for our patients," said Dr. Ghohestani, ... a long time provider of aesthetic medicine, we wanted to ...
Cached Medicine Technology:Reportlinker Adds Personalized Medicine - Scientific & Commercial Aspects 2Reportlinker Adds Personalized Medicine - Scientific & Commercial Aspects 3San Antonio's Texas Institute of Dermatology, Laser and Cosmetics Adds Alma Lasers Harmony XL Cosmetic Laser to Offer Advanced Rejuvenation Treatments to Patients 2
(Date:5/24/2015)... Scottsdale, Arizona (PRWEB) May 24, 2015 ... hired former Millennial Media strategy executive Jay Krihak ... as Medicx looks to ramp up its expertise ... services of the Pharmaceutical and Health sectors. , ... ad tech executive. Most recently, Krihak led sales ...
(Date:5/23/2015)... (PRWEB) May 23, 2015 On May ... powers of a youngster's yogic power learned through meditation ... Nithyananda Swami in Bangalore, India. , Yogamaatha, a nine-year-old ... than 50 high profile professionals attending the 2015 Business ... reading fluently -- blindfolded. , In a demonstration ...
(Date:5/23/2015)... On May 16, the team at Farrell’s ... 5k mud obstacle run that raised funds for multiple sclerosis. ... and the reason we participated was to support people living ... Farrell’s eXtreme Bodyshaping. “One-hundred percent of the funds raised go ... was not only attended by eXtreme Bodyshaping staff, but members ...
(Date:5/23/2015)... Viejo, CA (PRWEB) May 23, 2015 Add ... from Pixel Film Studios. , It's as simple as ... as utilizing the included tool for full effect. , ... filmed on high-dynamic range 5k sensors making this the ultimate ... The prismatic flares included in this package are movie files ...
(Date:5/22/2015)... The American College of Traditional Chinese ... They will hold a webinar on the updates of ... on Classical Chinese Medicine. , Webinar – First Professional ... the Dean of Clinical Education, will lead this webinar ... Doctorate program. ACTCM is currently developing this degree program ...
Breaking Medicine News(10 mins):Health News:Medicx Media Solutions Expands Executive Team 2Health News:Nine-Year-Old Reads Blindfolded at Business Advocacy Summit 2Health News:Nine-Year-Old Reads Blindfolded at Business Advocacy Summit 3Health News:Farrell’s eXtreme Bodyshaping Team Runs through the Muck for MS 2Health News:Developers at Pixel Film Studios Release ProFlare 5K Prism for Final Cut Pro X. 2Health News:ACTCM Announces Upcoming June Events 2
... 17 (HealthDay News) -- Some doctors post unethical and ... need for more oversight of physicians, use of social ... "tweets" sent by 260 U.S. physicians, each with 500 ... percent were unprofessional. This means the tweets ...
... By Steven Reinberg HealthDay Reporter , THURSDAY, Feb. ... 14 in the United States are drinking beer, liquor and ... the surprise is that many of these underage drinkers aren,t ... them or smuggling alcohol out of the family liquor cabinet. ...
... exposure from cell phone use does not appear to ... significant amount, a study by University of Manchester scientists ... the UK Office of National Statistics to look at ... England between 1998 and 2007. The study, published ...
... Reinberg HealthDay Reporter , WEDNESDAY, Feb. 16 (HealthDay ... you take a sugar pill but believe it is medicine, ... the opposite may also be true. In the study, ... either were or were not receiving a powerful painkiller, remifentanil ...
... total knee replacement (TKR) are age 60 to 80. ... reduction in knee pain and a significant improvement in the ... raised about the decline in physical function over the long ... revealed today at the 2011 Annual Meeting of the American ...
... for New Jersey,s 12th Congressional District, has been chosen ... in honor of his work as an advocate for ... to expand America,s scientific workforce., Specifically, the award selection ... Science (AAAS) said that Rep. Holt "was selected on ...
Cached Medicine News:Health News:Some Docs May Use Twitter for 'Unprofessional' Messages: Report 2Health News:Many Kids Who Drink Get Liquor From Home: Report 2Health News:Many Kids Who Drink Get Liquor From Home: Report 3Health News:Cell-phone use not related to increased brain cancer risk 2Health News: Placebo Effect May Work in Reverse 2Health News: Placebo Effect May Work in Reverse 3Health News:Total knee replacement patients functioning well after 20 years 2Health News:2010 AAAS Philip Hauge Abelson Award presented to the Honorable Rush Holt, Ph.D., for supporting science in Congress 2Health News:2010 AAAS Philip Hauge Abelson Award presented to the Honorable Rush Holt, Ph.D., for supporting science in Congress 3Health News:2010 AAAS Philip Hauge Abelson Award presented to the Honorable Rush Holt, Ph.D., for supporting science in Congress 4
SunGlide™ Stylette - Blue Neonatal. Use in 2.0 to 3.5mm tubes. 25/box....
Hollow Copper Tube with Suction Port 16.5....
Surgical Stainless Steel Adult 16.5....
FlexiSlip™ Plastic coated malleable metal core. Single use, Sterile, Latex Free. Soft distal tip flexes to reduce risk of trauma to patient. Malleable metal core is easy to shape. Low friction ...
Medicine Products: